TFAP2E and gastric cancer: The nanoparticles could release drugs in response to the overexpression of matrix metalloproteinases (MMP2/9) and collagenase IV in tumors and restore the expression of TFAP2E through DNA demethylation to resensitize gastric cancer cells to chemotherapy drugs.[104]